Basic Information
LncRNA/CircRNA Name | H19 |
Synonyms | NA |
Region | GRCh38_11:1995176-2001470 |
Ensemble | ENSG00000130600 |
Refseq | NR_002196 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | Pancreatic ductal adenocarcinoma |
ICD-0-3 | C25.3 |
Methods | qPCR, Luciferase reporter assay, RIP, etc. |
Sample | PDAC tissue, Human noncancerous pancreatic duct epithelial cell line HPDE6-C7 and pancreatic cancer cell lines PANC-1 and BxPC-3 |
Expression Pattern | up-regulated |
Function Description | In PDAC tissues, the expression of H19 and PFTK1 were upregulated; H19 knockdown suppressed the cell proliferation and migration of PDAC, while PFTK1 overexpression partially attenuated the suppressive effect of H19 knockdown. As analyzed by TCGA and predicted by online tools, miR 194 was negatively correlated with PFTK1 and might bind to both H19 and PFTK1, which was further confirmed by luciferase reporter and RNA immunoprecipitation assays. Moreover, the effect of H19 knockdown on PFTK1 protein and the cell proliferation and migration could be partially reversed by miR 194 inhibition; H19/miR 194 axis modulated PDAC cell proliferation and migration through PFTK1 downstream Wnt signaling. Results suggested that rescuing miR 194 expression in PDAC can inhibit lncRNA H19 and PFTK1 expression, subsequently suppressing PDAC cell proliferation and migration. |
Pubmed ID | 30474270 |
Year | 2018 |
Title | LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer |
External Links
Links for H19 | GenBank HGNC NONCODE |
Links for Pancreatic ductal adenocarcinoma | OMIM COSMIC |